fda bpc 157 safety concerns compounding FDA's Overreach on Compounded Peptides A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! The FDA just put peptides like BPC 157, TB 500, and KPV on the clock. As a compounding pharmacist, this is literally my world and most people don't understand the regulatory nuance behind FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea I am getting so many messages there is a lot to review and a lot unfolding quickly! I want to take my time with the information and have been studying on rotations. Hopefully will get yall an only

SKU: 52759097783 · From iglepidom.org